GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Price-to-Operating-Cash-Flow

Livzon Pharmaceutical Group (SZSE:000513) Price-to-Operating-Cash-Flow : 9.80 (As of May. 13, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Price-to-Operating-Cash-Flow?

As of today (2024-05-13), Livzon Pharmaceutical Group's share price is ¥40.84. Livzon Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.17. Hence, Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow Ratio for today is 9.80.

The historical rank and industry rank for Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:000513' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.85   Med: 19.32   Max: 45.56
Current: 9.79

During the past 13 years, Livzon Pharmaceutical Group's highest Price-to-Operating-Cash-Flow Ratio was 45.56. The lowest was 8.85. And the median was 19.32.

SZSE:000513's Price-to-Operating-Cash-Flow is ranked better than
74.85% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.545 vs SZSE:000513: 9.79

Livzon Pharmaceutical Group's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.99. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.17.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Livzon Pharmaceutical Group was 65.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.40% per year.

During the past 13 years, Livzon Pharmaceutical Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 102.10% per year. The lowest was -15.60% per year. And the median was 14.60% per year.


Livzon Pharmaceutical Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Price-to-Operating-Cash-Flow Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.88 17.56 19.75 10.97 10.03

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.80 14.09 10.96 10.03 8.76

Competitive Comparison of Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow falls into.



Livzon Pharmaceutical Group Price-to-Operating-Cash-Flow Calculation

Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=40.84/4.167
=9.80

Livzon Pharmaceutical Group's Share Price of today is ¥40.84.
Livzon Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.17.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Livzon Pharmaceutical Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines